EU Funded Projects
EFCCA is currently involved in 9 research projects co-funded by the European Union. These projects focus on innovative approaches to understanding, treating, and managing Inflammatory Bowel Disease (IBD) and other chronic conditions.
As a key patient organisation partner, EFCCA contributes by ensuring the patient perspective is embedded throughout the research process—from study design to dissemination—helping to shape more inclusive and impactful outcomes.
EFCCA Project Digest
ISSUE #6 is out now!
April 2025
Discover the latest updates from our EU-funded research projects, including GENEGUT, GlycanTrigger, miGut-Health, FIBROTARGET, METHYLOMIC, IDEA-FAST and ImmUniverse— as well as two new projects EFCCA is involved in: INTERCEPT and PerPrev-CID.
Stay informed on how we’re working to improve the lives of people with IBD.
INTERCEPT
EFCCA is partnering in the groundbreaking INTERCEPT project! This multi-million Euro research initiative, funded by the Innovative Health Initiative Joint Undertaking (IHI JU), marks a significant milestone in the fight against Crohn’s disease. By harnessing the power of predictive biomarkers, the project aims to shift Crohn’s from an incurable condition to one that can be effectively managed or even prevented.
EFCCA PROJECTS DIGEST
Newsletter
EFCCA Project Digest: Updates from EU Research on IBD
The EFCCA Project Digest is EFCCA's newsletter providing insights into innovative EU-funded research projects in which EFCCA is an active consortium partner. It highlights the latest developments in IBD research and showcases collaborative initiatives aimed at improving the lives of people living with IBD.
The Projects Digest is published every 2–3 months, and we hope it serves as a valuable resource for gaining deeper insights into our ongoing research initiatives.
